The product is sold in a 40ml spray bottle that if used as directed is a two-month supply.
Ralph Massa, Jr, Bi-Coastal Pharmaceutical’s president and COO, said: “I am pleased to announce the acquisition of Aquoral and confident that we will achieve significant sales levels well within the first year of marketing the product.
“Aquoral will soon be a trusted and proven household name to treat xerostomia as it is an extremely effective and easy to use product with no known adverse effects.”